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Objective. This study aimsto evaluate the eﬀect ofa multidisciplinary treatment of obesity on plasma concentrations ofseveralgut
hormones in fasting condition and in response to a mixed meal in children. Methods. Complete data were available from 36 obese
children (age 13.3±2.0yr). At baselineandafter the 3-monthmultidisciplinarytreatment, fasting andpostprandial bloodsamples
were takenforglucose,insulin,ghrelin,peptide YY(PYY),andglucagon-likepeptide 1(GLP-1).Results.BMI-SDSwassigniﬁcantly
reduced by multidisciplinary treatment (from 4.2 ± 0.7t o4 .0 ± 0.9, P<. 01). The intervention signiﬁcantly increased the area
under the curve (AUC) of ghrelin (from 92.3 ± 18.3t o9 7 .9 ± 18.2p g / L ,P<. 01), but no signiﬁcant changes were found for PYY
or GLP-1 concentrations (in fasting or postprandial condition).The insulinresistance index (HOMA-IR) remained unchanged as
well. Conclusion. Intensive multidisciplinary treatment induced moderate weight loss and increased ghrelin secretion, but serum
PYY and GLP-1 concentrations and insulin sensitivity remained unchanged.
1.Introduction
Childhood obesity has become a global problem [1]. Under-
standing the mechanisms that control energy balance and
fuel ﬂux in children is of paramount importance for the
design of eﬀective strategies to combat this health hazard.
The gastrointestinal tract plays a critical role in the control
offeeding behaviorand fuel metabolism. In response to food
intake, the gut produces a variety of hormones that inhibit
food intake, promote glucose induced insulin release, and/or
facilitate insulin action (e.g., glucagon-like peptide 1 (GLP-
1), peptide YY (PYY)) [2–4]. Conversely, in the absence
of food, the stomach produces ghrelin, which stimulates
appetite to initiate feeding [4, 5].
In a number of studies, plasma levels of ghrelin in obese
children were compared with those of normal weight con-
trols. Generally, the plasma ghrelin concentration of obese
children is lower in fasting condition [6–10], whereas the
decline in response to glucose ingestion varies as a function
of insulin sensitivity; the decline appears to be less profound
in insulin resistant obese children [6, 11], although the data
are equivocal[12].Weightloss tends tonormalize circulating
ghrelin levels [8, 10, 13], although this is still a subject for
debate [5, 14].
In fasting condition, plasma GLP-1 and PYY levels were
reported to be similar in obese and lean children [9, 15–18],
but in other studies lower PYY [19] and lower GLP-1 were
found in obese children [20]. Postprandial concentrations
of the two hormones are consistently lower in obese versus
normal weight peers [15, 20, 21]. The few studies that have
examined the eﬀect of weight loss on the release of these
hormones in obese children found signiﬁcantly increased
fasting PYY [19] and (surprisingly) decreased fasting GLP-
1[ 18] after weight reduction.2 ISRN Endocrinology
Because gut hormones are intimately involved in the
control of energy balance, better understanding of intestinal
endocrine (mal) function in obese children may contribute
tothedevelopmentofstrategies totreat theircondition.Here
we aim to evaluate the eﬀect of a 3-month multidisciplinary
intervention program to reduce the bodyweight of obese
children on plasma gut hormone concentrations in fasting
condition and in response to a standard meal.
2.Materialsand Methods
2.1. Participants, Study Design, and Settings. This study is
part of a randomized clinical trial on the eﬀect of multidisci-
plinary treatment on childhood obesity [22]. Here the eﬀects
of lifestyle intervention on various clinical and physiological
features of the obese children in the intervention group
are analyzed. Characteristics of the obese control group as
well as treatment eﬀe c to v e rt h ec o u r s eo f1a n d2y e a r s
followup were the topic of a previous study [23]. The study
inclusion criteria were simple obesity (as deﬁned by Cole
[24]), age 8–17 years, and referral to a pediatrician. Potential
participants were excluded if their knowledge of the Dutch
language, intelligence, or social skills were insuﬃcient to
participate in the trial. Other exclusion criteria were use of
medication that might have an eﬀect on weight loss, medical
comorbidity (e.g., hypothyroidism, high dose of glucocor-
ticoids, diabetes mellitus) that could aﬀect trial outcome,
or previous enrollment in another cognitive behavioral
treatment program with a focus on reducing body weight.
Fortychildrenwererandomizedtotheinterventiongroup,of
whom36completedthetreatment. The studywas conducted
according to the “Declaration of Helsinki”, and approval
was obtained from the regional medical ethical committee
South West Holland. All parents and children gave their
written informed consent after they had been given detailed
writtenexplanationsoftheaimsofthestudy,discomfort,and
inconvenience, and the option to withdraw at any time.
2.2. Intervention. The multidisciplinary lifestyle treatment
of the intervention group consisted of a screening phase
of individual counseling of the children with their parents,
followed by an intensive phase of group sessions during
three months. The group treatment consisted of 7 group
meetings for the children, 5 separate parent meetings, and
1 parent meeting together with the children. Meetings of 2.5
hours were held once every 2 weeks. The children meetings
were held on weekday afternoons at the hospital. The 5
separate parent meetings were provided on weekdays after
working hours. Subsequently, refresh follow-up sessions (2-
3 sessions/year) were oﬀered for a total period of two years
(Table 1).
2.3.Clinical Measures. Inthispaper,themeasurementstaken
at baseline (T1) and after 3 months treatment (T2) are
analyzed and discussed. Weight was measured to the nearest
of 0.1kg using an electronic scale (SECA 911, Vogel & Halke,
Hamburg,Germany) andheighttothenearest of0.1cmwith
a stadiometer (Holtain, limited, Crymych, Dyfed, Britain)
in underwear and barefoot by an experienced assistant.
T h eB M Iw a sc a l c u l a t e da sw e i g h t / h e i g h ts q u a r e d( k g / m 2).
Subjects were classiﬁed as obese using BMI gender- and age-
speciﬁc international cutoﬀ levels [24]. BMI was expressed
as standard deviation score (SDS)for Dutchreferences using
the LMS method [26]. Pubertal development was recorded
by the pediatrician according to Tanner [27].
2.4. Mixed Meal Tolerance Test. T h ec h i l d r e nw e r ea s k e dt o
consume a daily amount of at least 150g carbohydrates three
days prior to the mixed meal tolerance test and to continue
their normal daily physical activities. The day before the test
the subjects were asked not to consume any food or drinks
after 10 pm, with the exceptionof tap water. Onthe morning
of themixedmeal tolerancetest,thefasting state was verbally
conﬁrmed by the participant and a parent. A catheter was
placed in an antecubital vein for blood sampling. Fasting
blood samples were taken twice with a 15-minute interval
(t =− 15 and t = 0). After the second fasting blood sample
was taken, the participants received a mixed meal bolus
of 200mL (Nutridrink Yoghurt Style, Nutricia, Zoetermeer,
The Netherlands). The mixed meal bolus consisted of 49%
carbohydrates, 35% lipids, and 16% proteins, with a total
caloric content of 300kcal. After the consumption of the
mixed meal bolus, blood samples were takentwo more times
with a 15-minute interval (t = 15 and t = 30) and four
times with 30-minute intervals (t = 60, t = 90, t = 120,
and t = 150). Blood samples were analyzed for total ghrelin,
PYY, GLP-1, glucose, and insulin.
2.5. Laboratory Analysis. Tubes for blood collection of GLP-
1, PYY, and ghrelin and the inhibitor dipeptidyl peptidase
IV (DPP-IV) (Linco Research, St. Charles, MO, USA) were
placed on ice. Immediately after blood sampling, DPP-IV
was added to tubes for measurement of GLP-1 and PYY
to prevent degradation of these hormones. Blood samples
for GLP-1, PYY, and ghrelin were centrifuged within one
hour after sampling and stored at −80◦C until analyzed.
Baseline and T2 samples were analyzed in the same batches
for all three hormones. Serum GLP-1 concentrations were
measured by a highly speciﬁc enzyme-linked immunosor-
bent assay (human active GLP-1 ELISA Kit EGLP-35K,
Linco Research, St.Charles, MO, USA;intra-assay coeﬃcient
of variation 8 ± 4.8%; interassay coeﬃcient of variation
7.4 ± 1.1%; sensitivity 2pM/L). PYY (3–36) concentration
was determined by human radioimmunoassay (RIA) (PYY-
67HK RIA Kit A 0.056, LincoResearch, St. Charles, MO,
USA;intra-assay coeﬃcient ofvariation 5.5–8.5%;interassay
coeﬃcient of variation 2.9–9.4%; accuracy 86.9 ± 5.2%).
Total serum ghrelin was determined by human RIA as well
(Ghrelin Total RIA GHRT-89HK Kit A 0.056 MBQ, Linco
Research, St. Charles, MO, USA; intra-assay coeﬃcient of
variation 0.9–1.3%; interassay coeﬃcient of variation 6.2–
7.8%; sensitivity 30pg/mL).
Glucose was analyzed from lithium heparine plasma
by the glucose-oxydase method with the Unicel D × C
800 (Beckman Coulter, Woerden, the Netherlands). Plasma
insulin concentration was measured by RIA (DSL-1600,ISRN Endocrinology 3
Table 1: Characteristics of the family-based multidisciplinary lifestyle intervention.
Components Description
Screening
phase/individual
counseling
During the screening phase, children and their parents were interviewed at two separate occasions and all
individually by the multidisciplinary team consisting of a dietitian, a child physiotherapist, a child psychologist,
and a social worker. Throughout those two separate meetings, an individual advice was given by the
multidisciplinary team, based on the personal situationof each participating family.
Individual
nutritional
advice
A 3-day dietary recall (1 weekend day included) was used by the dietitian to get more insight in dietary habits of
the children. Information was provided about nutrition and healthy eating behavior according to the traﬃc
light nutritional list [25]. The traﬃc light nutritional list identiﬁes several main food groups (fruits, vegetables,
grains, milk and other dairy products, meat, ﬁsh, and others). Foods within each group were color-coded so as
to reﬂect the caloric density per average serving and Dutch standards for healthy nutrition. The colors are green
for “go”, orange for “approach with caution”, and red for “stop”. The children and parents were involved in
planning their own daily diet for themselves according to the traﬃc light nutritional list.
Individual
physical activity
counseling
To obtain insight in the child’s general physical activity behavior during the week, a physical activity
questionnaire was ﬁlled out by a child physiotherapist. Children were asked about how they traveled to school
(by foot, by bicycle, by public transportation, or by car), physical ﬁtness classes at school, spire time sport
activities, and daily computer and TV use as well as the duration spend at all these activities. The information
from this questionnaire was used for advice on how to increase and optimize physical activity during everyday
life, such as walking to nearby destinations and reducing sedentary activities (computer and TV use).
Individual
psychological
counseling
By means of motivational interviewing, the child psychologist helped the children to adapting to a new lifestyle
in order to reduce body weight. Before the child started with the group sessions,individual treatment goals
(reduction of 10% of body weight during 3 months of group sessions) were written down in a contract to avoid
disappointment.
Children’s
group meetings
Most children with obesity have negative experiences with group activities. For example, they are often not
included in social events or chosen last by peers during sport activities. Therefore, during the ﬁrst session much
time is spent in getting acquainted with each other. A good group bond is important for the eﬀect of the
treatment because peer support can be very helpful in the treatment of obese children. The main educational
focus of the ﬁrst two meetings is on nutritional informationof a healthy eating pattern and the balance between
energy intake and energy expenditure. During the subsequent meetings, emphasis was put in self-control
techniques to cope with diﬃcult situations (e.g., birthday parties, holidays,lunch breaks at school, being at
home alone). Problem solving alternatives are debated (e.g., to avoid a situation, doing something else,
participate in a situation and eat less, or participate followed by extra exercise afterwards). Other
psychoeducational topics reviewed were self-reward (when coping well with a diﬃcult situation) and
self-regulation situations (makinga plan how to integrate healthy behavior in daily living). Stimulus control
was also one of the psychoeducational topics (remove unhealthy stimuli at home, encourage healthy behavior,
eat at the dinner table, reduction of environmental stimuli linked to eating). Topics of the last two meetings
were self-image (focus on positive things about themselves) and coping strategies on dealing with teasing.
Parent group
meetings
Topics discussed during the parent meetings included the necessity to change their own lifestyle as well,
informationon healthy nutrition (product information,quantities, eating moments,eating locations),and how
to help their children. Parents received advice on parenting styles (boundaries setting with regard to eating
behavior, giving positive feedback). During the last meeting, a therapist discusses the role of all other family
members with regard to the treatment in the family (e.g., are other family members supportive, how do they
cope with the lifestyle changes).
Follow-up
meetings
In order to maintain the newly learned behavior, refresh follow-up meetings were given during the ﬁrst two
years (2-3 meetings/year). The child psychologist and the social worker organize this follow-up meetings. The
topics repeated were problem solving techniques and relapse prevention techniques.
Beckman Coulter, Woerden, the Netherlands; intra-assay
coeﬃcient of variation 4.5–8.3%; interassay coeﬃcient of
variation 4.7–12.2%; sensitivity 1.3µU/mL). An index for
insulin resistance was calculated according to the Home-
ostasis Assessment Model for insulin resistance (HOMA-
IR) formula: (fasting insulin (µU/mL) × fasting glucose
(mmol/L))/22.5 [28].
2.6. Statistical Analysis. The analysis was performed using
the Statistical Package for Social Science SPSS, version 17.0
for Windows (SPSS Inc., Chicago, IL, USA), and the level
of signiﬁcance was set at P<. 05. Data were checked for
normality before analysis, using descriptive statistics for
skewness, kurtosis,andShapiro-Wilktest.Theoutcomevari-
ables for insulin were transformed to the natural logarithm.
Data were expressed as mean ± standard deviation (con-
tinuous variables) and as count and percentage (categorical
variables) unless otherwise deﬁned. Valuesforthe area under
the curve (AUC) of 165min (from t =− 15 to t = 150min)
were calculated according to the trapezoid rule.
Paired t-tests were used to explore diﬀerence of the
outcome variables after treatment, in total 16 paired t-
tests were performed. A separate ANCOVA analysis was
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Figure 1: Mean plasma levels (±2SE) of Glucose (a) and Insulin (b) in response to a mixed meal at baseline (T1) versus after intervention
(T2).
hormones over time (T2 versus T1) was eﬀected by gender,
age, pubertal stage, or change in BMI-SDS. In the ANCOVA
analysis, the changes in AUC of the gut hormones were used
as dependent variables, time (T2 versus T1) and gender as
ﬁxed variables, and age, pubertal stage, and change in BMI-
SDS as covariates.
3.Results
3.1. Subjects. Forty subjects (18M/22F; age: 13.3 ± 2.0y e a r s )
were enrolled in the study, and 36 children completed both
study occasions. One subject withdrew before all baseline
measurements were completed, one discontinued treatment
and two did not show up at T2 for personal reasons.
No signiﬁcant diﬀerence in baseline BMI-SDS or age was
observed between completers (4.2 ± 0.7 SDS; 13.3 ± 1.8
years) andnoncompleters (4.3±0.3;13.3±3.1y ear s ).R es ults
are presented for the 36 children completing both study
occasions (18M/18F).
3.2. Anthropometry and Metabolic Parameters. Changes be-
tweenboth study occasions in anthropometry and metabolic
parameters are shown in Table 2. A signiﬁcant reduction
of BMI-SDS was found after 3 months of multidisciplinary
lifestyle treatment.
Fasting plasma glucose and insulin concentrations (and
consequently HOMA-IR) were similar at baseline (T1) and
after treatment (T2). The AUC of plasma glucose and insulin
concentrations in response to the meal was also not aﬀected
by intervention (Figures 1(a) and 1(b)).
3.3.GutHormones. The ghrelin AUCin response tothemeal
was slightly, but signiﬁcantly increased after treatment. Fast-
ing levels were not signiﬁcantly aﬀected (Figure 2(a)). The
treatment didnotaﬀecteitherfasting orpostprandial plasma
GLP-1 and PYY concentrations (Figures 2(b) and 2(c)).
The ANCOVA analysis for change of circulating ghrelin
and PYY levels between the two study occasions showed
that the change in BMI-SDS during the study period was
a signiﬁcant covariate (P<. 01 and P = .01, resp.).
This ﬁnding suggests that weight loss aﬀects the plasma
PYY concentration. Gender, age, and pubertal stage were no
signiﬁcant covariates.
4.Discussion
A 3-month multidisciplinary lifestyle intervention in obese
children reduces adiposity (BMI-SDS) and elevates plasma
ghrelin levels in response to a meal. In contrast, it does not
aﬀect circulating PYY and GLP-1 concentrations in fasting
condition nor in response to food intake. Notably, changes
of ghrelin and PYY AUC were signiﬁcantly inﬂuenced by the
change of BMI-SDS, which suggests that the production of
these gut peptides is sensitive to body weight (change). We
speculate that the impact of our intervention on BMI was
too modest to reach statistical signiﬁcance for the diﬀerence
between average levels.
Various studies have shown an increase of fasting plasma
ghrelin levels after weight loss in obese children [8, 10,
13]. However, the amount of weight lost was substantially
greater in these studies than in ours. Other studies in whichISRN Endocrinology 5
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Figure 2: Mean plasma levels (±2SE) of Ghrelin (a), GLP-1 (b), and PYY (c) in response to a mixed meal at baseline (T1) versus after
intervention (T2).
weight loss was more modest did not observe signiﬁcant
changes of fasting circulating ghrelin levels either [5, 14].
Interestingly, the change of plasma ghrelin concentrations
was signiﬁcantly and inversely associated with the change
of BMI-SDS, which conﬁrms that body weight (or caloric
restriction) does inﬂuence ghrelin levels. This suggests that
the eﬀect of our intervention on weight reduction was too
small to aﬀect average fasting circulating ghrelin. It has been
suggested that weight loss achieved by dietary or exercise
treatment initiates compensatory changes in appetite and
energy expenditure that hinders maintenance of the reduced
body weight [4, 5]. Ghrelin release increases before a meal to
initiate food intake [4, 29]. Thus, it isconceivablethat higher
(fasting) ghrelin concentrations in response to weight loss
set oﬀ a greater hunger signal, which obviously renders the
treatment goal more diﬃcult to reach.6 ISRN Endocrinology
Table 2: Clinical and physiological parameters of the subjects with complete data (N = 36).
Variables Baseline (T1) After (T2) P Value∗
BMI-SDS 4.2 ± 0.74 .0 ±0.9 .003
HOMA-IR 4.2 ± 2.54 .1 ±3.0N S
Glucose (fasting) (mmol/L) 5.2 ± 0.45 .3 ±0.4N S
Glucose AUC (165min × mmol/L) 905 ± 67 896 ±86 NS
Insulin (fasting) (mU/L) 18.0 ± 10.71 7 .4 ±12.5N S
Insulin AUC (165min × U/L)† 10.3 ± 6.11 1 .0 ±8.0N S
Ghrelin (fasting) (pg/mL) 612 ± 143 641 ±144 NS
Ghrelin AUC (165min × pg/L)† 92.3 ± 18.39 7 .9 ±18.2 .006
PYY (fasting) (pg/mL) 90.2 ± 34.69 5 .5 ±32.8N S
PYY AUC (165min × pg/L) 16.3 ± 4.61 5 .3 ±5.0N S
GLP-1 (fasting) (pM/L) 2.6 ± 0.92 .5 ±0.9N S
GLP-1 AUC (165min × pM/L) 567 ± 192 552 ±197 NS
∗P value T2 versus T1 (paired t-test).
It is unclear why serum ghrelin levels are low in obese
children. Perhaps overfeeding is involved (feeding dampens
ghrelin release) and the metabolic changes associated with
obesity, such as insulin resistance [4]. Indeed, a previous
study revealed that the change of HOMA-IR after weight
loss correlates inversely with the change in plasma ghrelin in
obese children, suggesting that these changes are mechanisti-
cally linked [5, 8].
GLP-1 and PYY are gut peptides produced in response
to food intake. Both peptides provide a satiety signal to the
brain to terminate eating [4]. Fasting plasma concentrations
of either peptide were reported to be normal [9, 15–18]o r
reduced [19, 20] in obese children, whereas postprandial
levels are consistently lower [15, 20, 21]. We show that
modest weight reduction does not have an impact on fasting
orpostprandial GLP-1 and PYY levelsin obese children. This
is in apparent contrast to the results of the very few previous
studies evaluating the eﬀect of weight loss on plasma gut
hormone levels in children. Substantial weight loss (≥0.5
BMI-SDS) appears to be accompanied by an increase in
fasting PYY [19] and (surprisingly) a decrease in (fasting)
GLP-1 [15, 18].
It is important to emphasize that our multidisciplinary
lifestyle treatment resulted in a statistically signiﬁcant but
only modest weight reduction. It is therefore conceivable
that a more substantial average weight reduction of ≥0.5
BMI-SDS would have had more explicit eﬀects on (average)
gut hormone concentrations. This postulate is supported by
other studies, but also by our own data showing that the
amount of weight loss is correlated with counterregulatory
changes of plasma ghrelin and PYY concentrations, which
can contribute to the diﬃculties that patients encounter
when they try to lose weight. Thus, GLP-1 analogues or
dipeptidyl-peptidase IV inhibitors may help obese children
to lose weight in response to lifestyle measures.
In conclusion, only a few studies so far have evaluated
the eﬀect of weight reduction on (postprandial) PYY, GLP-
1, or ghrelin concentrations in children with obesity. We
show that modest weight reduction by lifestyle intervention
slightly elevates ghrelin levels, whereas it does not aﬀect PYY
or GLP-1 concentrations.
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